Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

NCT00275509 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure, Chronic

Interventions

DRUG: Thymoglobulin
DRUG: Daclizumab
OTHER: Plasmapheresis
DRUG: Mycophenolate mofetil
DRUG: Tacrolimus
DRUG: Dexamethasone
DRUG: Prednisone
DRUG: Cytogam

Sponsor

Johns Hopkins University